Longitudinal Evaluation of GTP1 as a PET Radioligand for Imaging Tau in the Brains of Patients With Prodromal, Mild, and Moderate Alzheimer's Disease Compared to Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 08 Dec 2017
At a glance
- Drugs Florbetapir F 18 (Primary)
- Indications Alzheimer's disease
- Focus Diagnostic use
- Sponsors Genentech
- 24 Oct 2017 Planned End Date changed from 1 Jan 2018 to 11 Jan 2018.
- 24 Oct 2017 Planned primary completion date changed from 1 Jan 2018 to 11 Jan 2018.
- 10 Jun 2017 Biomarkers information updated